Victor Alemede
Victor Alemede publishes mostly in Economics and Econometrics, Geriatrics and Gerontology and Public Health, Environmental and Occupational Health, on topics such as Pharmaceutical Economics and Policy, Pharmaceutical Practices and Patient Outcomes and Healthcare Policy and Management.
- World rank
- #5,014,413 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #301,819 of 367,258
- Works
- 16
- Citations
- 55
- Citations per work
- 3.4
What does Victor Alemede research?
Victor Alemede's work is mostly in Economics, Econometrics and Finance (38%), Medicine (15%), Immunology and Microbiology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else638.4%
- Social Sciences638.2%
- Health Sciences214.7%
- Medicine214.7%
- Physical Sciences15.8%
- Computer Science02.9%
- Environmental Science02.9%
- Life Sciences02.9%
- 1Economics and Econometrics38% of their works
- 2Geriatrics and Gerontology9% of their works
- 3Public Health, Environmental and Occupational Health6% of their works
- 4Immunology3% of their works
- 5Artificial Intelligence3% of their works
- 6Management, Monitoring, Policy and Law3% of their works
Research topics
- Pharmaceutical Economics and Policy
- Pharmaceutical Practices and Patient Outcomes
- Healthcare Policy and Management
- Health Systems, Economic Evaluations, Quality of Life
- Biotechnology and Related Fields
- Biosimilars and Bioanalytical Methods
- Pharmaceutical industry and healthcare
- Law, AI, and Intellectual Property
Which keywords describe Victor Alemede's research?
The keywords of their largest research topics: Pharmaceutical Industry, Drug Development Costs, Generic Drugs, Cost-effectiveness Analysis, Health Care Spending, Inappropriate Medication Use, Insurance Markets and Polypharmacy.
- Immunogenicity
- Conflict of Interest
- Artificial Intelligence
- Global Collaboration
- Polypharmacy
- Inappropriate Medication Use
- Cost-effectiveness Analysis
- Drug Development Costs
- Pharmaceutical Industry
- Generic Drugs
- Health Care Spending
- Insurance Markets
- Quality of Life
- Health Biotechnology
- Biosimilars
- Cyberbiosecurity
- Research Outcome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Pharmaceutical Industry82 topics
- Drug Development Costs71 topic
- Generic Drugs71 topic
- Cost-effectiveness Analysis31 topic
- Health Care Spending31 topic
- Inappropriate Medication Use31 topic
- Insurance Markets31 topic
- Polypharmacy31 topic
- Quality of Life31 topic
- Global Collaboration21 topic
- Health Biotechnology21 topic
- Artificial Intelligence11 topic
- Biosimilars11 topic
- Conflict of Interest11 topic
- Cyberbiosecurity11 topic
- Immunogenicity11 topic
- Research Outcome11 topic
Where does Victor Alemede work?
Victor Alemede's main affiliation in the publication record is Oldham Council, United Kingdom.
How many publications and citations does Victor Alemede have?
OpenAlex counts 16 works and 55 citations for Victor Alemede, an h-index of 5, ranking #5,014,413 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Victor Alemede. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.